A Comparison of Computed Tomography Perfusion-Guided and Time-Guided Endovascular Treatments for Patients With Acute Ischemic Stroke

被引:34
作者
Hassan, Ameer E. [1 ]
Zacharatos, Haralabos [1 ]
Rodriguez, Gustavo J. [1 ]
Vazquez, Gabriela [1 ]
Miley, Jefferson T. [1 ]
Tummala, Ramachandra P. [1 ]
Suri, M. Fareed K. [1 ]
Taylor, Robert A. [1 ]
Qureshi, Adnan I. [1 ]
机构
[1] Univ Minnesota, Dept Neurol, Zeenat Qureshi Stroke Res Ctr, Minneapolis, MN 55455 USA
基金
美国国家卫生研究院;
关键词
acute ischemic stroke; computed tomographic perfusion; endovascular treatment; thrombectomy; thrombolysis; INTRAARTERIAL THROMBOLYSIS; CT ANGIOGRAPHY; VOLUME; PROUROKINASE; ALTEPLASE; ADMISSION; DIFFUSION; ACCURACY; PENUMBRA; TRIAL;
D O I
10.1161/STROKEAHA.110.586685
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose-The role of CT perfusion (CT-P) imaging for the selection of patients with acute ischemic stroke who may benefit from endovascular treatment is not defined. The objective of this study was to determine whether CT-P-guided endovascular treatment improves clinical outcomes compared with standard endovascular treatment based on the time interval between symptom onset and presentation and noncontrast cranial CT imaging. Methods-A retrospective study was performed comparing the clinical characteristics, complications, and clinical outcomes of patients with acute ischemic stroke who were treated using endovascular modalities based on either CT-P imaging (CT-P-guided) or time interval between symptom onset and presentation and absence of intracerebral hemorrhage or extensive ischemic changes on noncontrast cranial CT scan (time-guided). Results-The rates of partial and complete recanalization were similar between the CT-P- and time-guided treatment groups (n=61 [88%] versus n=103 [81%]; P=0.52) regardless of whether they received intravenous recombinant tissue plasminogen activator before endovascular treatment. Comparing the CT-P- guided with the time-guided patients, favorable discharge outcome (modified Rankin Scale 0 to 2) was observed in 23 (32%) versus 41 (33%) of the patients, respectively (P=0.9). In-hospital mortality was observed in 15 (21%) of CT-P- and 29 (23%) of time-guided patients (P=0.74). Conclusion-CT-P- guided endovascular treatment did not increase the rate of short-term favorable outcomes among patients with acute ischemic stroke. Prospective studies are required to validate the CT-P criteria and protocols currently in use before incorporating CT-P as a routine modality for patient selection for endovascular treatment. (Stroke. 2010;41:1673-1678.)
引用
收藏
页码:1673 / 1678
页数:6
相关论文
共 32 条
[1]   Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy [J].
Barber, PA ;
Demchuk, AM ;
Zhang, JJ ;
Buchan, AM .
LANCET, 2000, 355 (9216) :1670-1674
[3]   The interventional management of stroke (IMS) II study [J].
Broderick, Joseph P. .
STROKE, 2007, 38 (07) :2127-2135
[4]  
Eastwood JD, 2003, AM J NEURORADIOL, V24, P1869
[5]   CT angiography with whole brain perfused blood volume imaging - Added clinical value in the assessment of acute stroke [J].
Ezzeddine, MA ;
Lev, MH ;
McDonald, CT ;
Rordorf, G ;
Oliveira-Filho, J ;
Aksoy, FG ;
Farkas, J ;
Segal, AZ ;
Schwamm, LH ;
Gonzalez, RG ;
Koroshetz, WJ .
STROKE, 2002, 33 (04) :959-966
[6]   Intra-arterial prourokinase for acute ischemic stroke - The PROACT II study: A randomized controlled trial [J].
Furlan, A ;
Higashida, R ;
Wechsler, L ;
Gent, M ;
Rowley, H ;
Kase, C ;
Pessin, M ;
Ahuja, A ;
Callahan, F ;
Clark, WM ;
Silver, F ;
Rivera, F .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (21) :2003-2011
[7]   Adventures in the pathophysiology of brain ischemia: Penumbra, gene expression, neuroprotection - The 2002 Thomas Willis Lecture [J].
Ginsberg, MD .
STROKE, 2003, 34 (01) :214-223
[8]   The Desmoteplase In Acute Ischemic Stroke Trial (DIAS) - A phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase [J].
Hacke, W ;
Albers, G ;
Al-Rawi, Y ;
Bogousslavsky, J ;
Davalos, A ;
Eliasziw, M ;
Fischer, M ;
Furlan, A ;
Kaste, M ;
Lees, KR ;
Soehngen, M ;
Warach, S .
STROKE, 2005, 36 (01) :66-73
[9]   Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II) [J].
Hacke, W ;
Kaste, M ;
Fieschi, C ;
von Kummer, R ;
Davalos, A ;
Meier, D ;
Larrue, V ;
Bluhmki, E ;
Davis, S ;
Donnan, G ;
Schneider, D ;
Diez-Tejedor, E ;
Trouillas, P .
LANCET, 1998, 352 (9136) :1245-1251
[10]  
HACKE W, 1995, JAMA-J AM MED ASSOC, V274, P1017, DOI 10.1001/jama.274.13.1017